SCHEMBL30477362

SCHEMBL30477362

NCC[C@H](N)C(=O)N[C@@H](Cc1cccc2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 2/20 0.53
HRH4 Q9H3N8 1/20 0.49
MME P08473 2/20 0.48
ACE P12821 2/20 0.48
CPA1 P15085 1/20 0.48
ACE2 Q9BYF1 1/20 0.48
MMP9 P14780 2/20 0.47
MMP8 P22894 2/20 0.47
MMP14 P50281 1/20 0.47
CTNNB1 P35222 1/20 0.47
LCK P06239 2/20 0.46
MMP2 P08253 1/20 0.44
OPRD1 P41143 1/20 0.44
NAALAD2 Q9Y3Q0 1/20 0.44
ERAP2 Q6P179 1/20 0.43
HPGD P15428 1/20 0.43
MC4R P32245 1/20 0.42
MC5R P33032 1/20 0.42
MC1R Q01726 1/20 0.42
CTSS P25774 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30477359 0.89 FOLH1 (0.58) FOLH1HRH4MMEACECPA1
SCHEMBL29533784 0.86 FOLH1 (0.52) FOLH1HRH4MMEACECPA1
SCHEMBL30477360 0.82 FOLH1 (0.51) FOLH1MMEACECPA1ACE2
SCHEMBL4599154 0.80 FOLH1 (0.51) FOLH1HRH4MMEACECPA1
SCHEMBL4599159 0.80 FOLH1 (0.51) FOLH1HRH4MMEACECPA1
SCHEMBL31510462 0.79 MME (0.57) FOLH1HRH4MMEACECPA1
SCHEMBL31720502 0.79 ERAP2 (0.73) ACEMMP9MMP8MMP2ERAP2
SCHEMBL29892410 0.78 NAALAD2 (0.67) FOLH1NAALAD2HPGD
SCHEMBL29350328 0.78 ERAP2 (0.65) ACEERAP2
SCHEMBL7857962 0.78 HRH4 (0.51) HRH4MMEACECPA1ACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12540161-B2 Linkers BICYCLETX LIMITED (GB) 2026-02-03 US disclosed
CN-116348476-A Peptide-based linkers 拜斯科技术开发有限公司 2023-06-27 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12540161-B2 Linkers ADM2, CDA, DCTD FOLH1 26/4885HRH4 391/4885MME 869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.